BSECompany Update22h ago · 13 Aug 2026, 06:27 pm
Change in Management
Bandaram Pharma Packtech Ltd · 524602
✦ AI SummaryMgmt Change
Bandaram Pharma Packtech Ltd has announced the re-appointment of Mr. Suryaprakasa Rao Bommisetti as an Independent Director for a 2nd term of 5 consecutive years and M/s. M.M. Reddy & Co. as statutory auditors for a period of 3 years.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Bandaram Pharma Packtech Ltd - 524602 - Announcement under Regulation 30 (LODR)-Change in Management
Attachments (1)
📄pdf
Download →
1f2141b4-d536-491e-8734-69d00f112e6a.pdf
View document text
FNCIFREM
Date: 13.08.2026
BSE Limited
P.J. Towers, Dalal Street
Mumbai - 400001
Sub: Outcome of Board Meeting held on 13.08.2026 under Regulation 30 and Regulation
33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Ref: Company’s Letter dated 06.08.2026
Unit: Bandaram Pharma Packtech Limited (Scrip Code: 524602)
Dear Sir/Madam,
With reference to the above-mentioned subject, this is to inform the Exchange that the meeting
of Board of Directors of Bandaram Pharma Packtech Limited was held on Thursday, the 13th day
of August, 2026 at 04.00 p.m. at the Registered Office of the Company at 601,5th Floor, Oxford
Towers, opp to Leela Palace Hotel, Old Airport Road, Kodihalli, Bangalore, Bangalore,
Karnataka, India, 560008. The Board has inter-alia considered and approved the following items:
1. Un-audited financial Results (Standalone and Consolidated) along with the Limited
Review Report (Standalone and Consolidated) for the quarter ended 30.06.2026.
(Enclosed)
2. Re-appointment of Mr. Suryaprakasa Rao Bommisetti as an Independent Director of the
Company for 2nd term of 5 consecutive years w.e.f., 07.03.2027, subject to the approval
of the members in ensuing annual general meeting. (Details annexed as Annexure A)
3. Re-appointment of M/s. M.M. Reddy & Co., Chartered Accountants as statutory auditors
of the company for a period of 3 years from the conclusion of this Annual general
Meeting to Annual general Meeting for the FY 2028-29, subject to the approval of the
members in ensuing annual general meeting. (Details annexed as Annexure A)
Web: www.bandaram.com
E.=.n:1.=IR.=.n4 PHFRM PFEKTEEH LIMITED
CIN:L93090KA1993PLC159827
Oxfordtowers, Unit No. 601, 5th Floor, OldAirport Road, Kodihalli, Bangalore-560008
EMail: info.bandorom@gmaiI.com Phone No. 08040952127
FNCIFREM
4. Director’s Report for FY 2025-26 and notice for convening Annual General Meeting
(AGM) for the Financial Year 2025-26.
5. Annual General meeting for the FY 2025-26 is scheduled to be held on Friday,
18.09.2026 at 11:00 a.m. through Video Conference/other Audio-visual means (OAVM).
The meeting concluded at 05.10 p.m.
We request you to kindly take note of the same in your records.
Thanking you.
Yours sincerely,
For Bandaram Pharma Packtech Limited
Deepak Reddy Bandaram
Chairman and Managing Director
(DIN: 07074102)
Encl: a/a
Web: www.bandaram.com
a.=.n:1.=IR.=.m FHFRM PFEKTEEH LIMITED
CIN:L93090KA1993PLC159827
Oxfordtowers, Unit No. 601, 5th Floor OldAirport Rood, Kodihalli, Bongolore-560008
EMail: info.bandorom@gmoil.com Phone No. 08040952127
FNCIFREM
Annexure A
Disclosures as required under Regulation 30 of Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI
Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026:
Particulars Mr. Suryaprakasa Rao M/s. M.M. Reddy & Co.,
Bommisetti Chartered Accountants
Reason for change viz. Re-appointment of R e - a p p o i n t m e n t o f M/s. M.M.
Resignation/ Mr. Suryaprakasa Rao Bommisetti Reddy & Co., Chartered
appointment as Independent Director of the Accountants as Statutory
Company. Auditors of the Company.
Date of Re-appointment for a term of 5 Terms of appointment: Re-
Appointment/Cessation years w.e.f. 07.03.2027. appointment for 2nd term of 3
and Terms of consecutive years from the
appointment conclusion of Annual General
Meeting for FY 2025-26 until
the conclusion of Annual
General Meeting for FY 2028-
29 as recommended by the
Audit Committee and approved
by the Board of Directors.
Brief profile Mr. Suryaprakasa Rao Bommisetti, M M REDDY & CO.,
qualified in 1995, has over 31 years Chartered Accountants is a
of experience in banking, auditing, partnership firm established on
finance, and consultancy. He 22 September 2003, with
worked for 5½ years in a Bank offices across Telangana,
handling audits, compliance, MIS Andhra Pradesh, and
reporting, statutory audit Karnataka, and associate
coordination, corporate advances, presence in Dubai, Singapore,
NPAs, and recovery matters. In and Hong Kong. With 9
practice, he has managed accounts partners and a team of 30+
finalization across diverse sectors, professionals, the firm offers
ROC and incorporation matters, and specialized expertise in audit,
liaison with RBI and government taxation, advisory, forensic
departments. His expertise covers audits, information systems
Web: www.bandaram.com
E.=.n:J.=IR.=m1 FHFRM FFEKTEEH LIMITED
CIN:L93090KA1993PLC159827
Oxfordtowers, Unit No. 601, 5th Floor, OldAirport Road, Kodiholli, Bangalore-560008
EMail: info.bandoram@gmaiI.com Phone No. 08040952127
FNCIFREM
accounting, audit, finance, advisory, audits, insolvency, government
and consultancy services. He has audits, stock audits, and public
also completed ICAI’s certificate finance. It is empanelled with
courses on Concurrent Audit of premier institutions including
Banks, Ind AS, and Public Finance IBA, CBI, SFIO, Telangana
& Government Accounting, along Police (EOW), SBI, IDBI,
with training from ICAI Registered SIDBI, IFCI, and major public
Valuers Organization. sector banks for forensic and
specialized audit assignments.
The firm has extensive
experience in stock audits,
concurrent audits, statutory
branch audits, and large
corporate banking assignments,
and currently serves as
Statutory Branch Auditor for
SBI and concurrent auditor for
leading bank branches.
Disclosure of Nil Not Applicable
relationships between
directors (in case of
appointment of a
director)
Affirmation that the To the best of our knowledge and Not Applicable
Director being information, we hereby affirm that
appointed is not Mr. Suryaprakasa Rao Bommisetti
debarred from holding is not debarred from holding the
the office of director office of Director by virtue of any
by virtue of any SEBI SEBI order or any other such
order or any other such authority.
authority
Shareholding if any NIL Not Applicable
Web: www.bandaram.com
EENEFREM FHFRM PFEKTEEH LIMITEEI
CIN:L93090KA1993PLC159827
Oxfordtowers, Unit No. 601, 5th Floor, OldAirport Road, Kodihalli, Bangalore-560008
EMoll: info.bondoram@gmoil.com Phone No. 08040952127
BANDARAM PHARMA PACKTECH LIMITED
CIN: L93090KA1993PLC159827
Regd Office: 601, 5th Floor, Oxford Towers, Opp. to Leela Palace Hotel, Old Airport Road, Kodihalli, Bangalore - 560008.
STATEMENT OF STANDALONE AND CONSOLIDATED UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30-06-2026 (Amtount Rs. in lakhs)
STANDALONE CONSOLIDATED
For the Quarter ended Year ended For the Quarter ended Year ended
S.No. Particulars 30.06.2026 31.03.2026 30.06.2025 31.03.2026 30.06.2026 31.03.2026 30.06.2025 31.03.2026
(Unaudited) (Audited) (Unadited) (Audited) (Unaudited) (Audited) (Unadited) (Audited)
I. Revenue from Operations 298.51 819.65 75.74 1,095.99 2,395.26 2,625.92 810.37 6 ,292.32
II. Other Income - - - 0.83 0.03 0.97 - 1 .80
III. Total income (I+II) 298.51 819.65 75.74 1,096.82 2,395.29 2,626.89 810.37 6,294.12
IV. Expenses
(a) Cost of Materials consumed 276.41 785.79 79.79 1,060.43 2,161.36 2,362.71 648.37 5 ,502.14
(b) Purchase of stock-in-trade - - -4.40 - - - - -
(c) Changes in inventories of finished - - - - -85.25 -109.51 -6.17
goods, - 116.86
w(do) rEkm-inp-lopyroeeg rbeesns eafnitsd esxtopcekn-sines-trade 28.17 54.63 10.74 87.75 73.16 225.48 54.60 3 90.65
(e) Finance Cost - - - 0.03 41.66 45.90 46.02 1 50.57
(f) Depreciation and amortisation
expenses - 0.05 0.05 0.21 20.37 24.87 13.44 97.37
(h)Other expenses 29.61 12.47 16.41 64.42 91.50 65.74 50.56 2 26.12
Total Expenses 3 34.19 8 52.94 1 02.59 1,212.84 2 ,302.80 2 ,615.19 8 06.82 6,249.99
V. Profit / (Loss) before and exceptional
items and Tax ( III-IV)
(35.68) (33.29) (26.85) (116.02) 92.49 11.70 3.55 44.13
VI. Exeptional Items - - - - - - - -
VII Profit / (Loss) from before tax (V-VI)
(35.68) (33.29) (26.85) (116.02) 92.49 11.70 3.55 44.13
VIII. Tax expense
Current Tax - - - - 24.05 3.04 0.89 1 1.47
Deferred Tax - ( 0.11) - (0.11) - ( 0.50) 0.19 4.51
IX.
[Showing first 8,000 characters — download PDF for full document]